Millendo Therapeutics, Inc.
Q4 2018 13F Holders
Symbol
MLND
CUSIP
60040X103
Type
Equity
Class
COM
Num filings
43
Total reported value, excl. options
$53.3 M
Compare 2018 Q4 to
2021 Q1
2020 Q4
2020 Q3
2020 Q2
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2019 Q1
Manager
Report Date
Value ($000)
Shares
Option Type